---
title: Parental and child's psychosocial and financial burden living with an inherited
  metabolic disease identified by newborn screening
date: '2024-08-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39189622/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240827181517&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Newborn screening (NBS) is one of the most effective measures of secondary
  prevention. While the benefit of NBS on the clinical long-term outcomes of children
  with inherited metabolic diseases (IMD) has been demonstrated, the potential burden
  of families living with an early diagnosed and treated child with an IMD has not
  been thoroughly investigated. The aim of this longitudinal questionnaire-based study
  on 369 families living with a child with an IMD was to investigate the psychosocial
  ...
disable_comments: true
---
Newborn screening (NBS) is one of the most effective measures of secondary prevention. While the benefit of NBS on the clinical long-term outcomes of children with inherited metabolic diseases (IMD) has been demonstrated, the potential burden of families living with an early diagnosed and treated child with an IMD has not been thoroughly investigated. The aim of this longitudinal questionnaire-based study on 369 families living with a child with an IMD was to investigate the psychosocial ...